Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients.
暂无分享,去创建一个
Jakob S. Jensen | V. A. Folcik | R. Ransohoff | C. Lucchinetti | R. Strieter | J. Frederiksen | F. Sellebjerg | T. Sørensen | J. Rottman | M. Tani | S. Qin | F. Sellebjerg | J. Jensen | V. Pierce
[1] C. Granger,et al. Cerebrospinal fluid abnormalities in a phase III trial of Avonex® (IFNβ-1a) for relapsing multiple sclerosis 1 Studies supported by the National Multiple Sclerosis Society (grants RG2019, RG2827); the NINDS (NS26321); and Biogen Inc. 1 , 1999, Journal of Neuroimmunology.
[2] R. Miller,et al. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[3] R. Weller. Pathology of Cerebrospinal Fluid and Interstitial Fluid of the CNS: Significance for Alzheimer Disease, Prion Disorders and Multiple Sclerosis , 1998, Journal of neuropathology and experimental neurology.
[4] R. Ransohoff,et al. Cutting Edge Commentary: Chemokine Regulation of Experimental Autoimmune Encephalomyelitis: Temporal and Spatial Expression Patterns Govern Disease Pathogenesis , 1998, The Journal of Immunology.
[5] B. Stokes,et al. Selective chemokine mRNA accumulation in the rat spinal cord after contusion injury , 1998, Journal of neuroscience research.
[6] H. Lassmann,et al. Immunopathology of multiple sclerosis: Report on an international meeting held at the Institute of Neurology of the University of Vienna , 1998, Journal of Neuroimmunology.
[7] C. Brosnan,et al. MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study , 1998, Journal of Neuroimmunology.
[8] P. Calabresi,et al. ELI-spot of Th-1 cytokine secreting PBMC's in multiple sclerosis: correlation with MRI lesions , 1998, Journal of Neuroimmunology.
[9] R. Bravo,et al. Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor. , 1998, Journal of immunology.
[10] J. Newcombe,et al. Expression of monocyte chemoattractant protein-1 and other β-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions , 1998, Journal of Neuroimmunology.
[11] F. Sellebjerg,et al. Costimulatory CD80 (B7-1) and CD86 (B7-2) on cerebrospinal fluid cells in multiple sclerosis , 1998, Journal of Neuroimmunology.
[12] M. Baggiolini. Chemokines and leukocyte traffic , 1998, Nature.
[13] J. Ernerudh,et al. CD4 and CD8 lymphocyte subsets in cerebrospinal fluid and peripheral blood from patients with multiple sclerosis, meningitis and normal controls , 1998, Acta neurologica Scandinavica.
[14] R. Ransohoff,et al. Do chemokines mediate leukocyte recruitment in post-traumatic CNS inflammation? , 1998, Trends in Neurosciences.
[15] E. Major,et al. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[16] C. Mackay,et al. Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes , 1998, The Journal of experimental medicine.
[17] B. Rollins,et al. Abnormalities in Monocyte Recruitment and Cytokine Expression in Monocyte Chemoattractant Protein 1–deficient Mice , 1998, The Journal of experimental medicine.
[18] C. Mackay,et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. , 1998, The Journal of clinical investigation.
[19] A. Luster,et al. Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.
[20] R. Rudick,et al. Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.
[21] M. Baggiolini,et al. CCR5 is characteristic of Th1 lymphocytes , 1998, Nature.
[22] E. Butcher,et al. Chemokines and the arrest of lymphocytes rolling under flow conditions. , 1998, Science.
[23] P. Allavena,et al. Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s , 1998, The Journal of experimental medicine.
[24] T. Sørensen,et al. Etiology and pathogenesis of multiple sclerosis. , 1998, Seminars in neurology.
[25] U. de Girolami,et al. Localization of HIV-1 co-receptors CCR5 and CXCR4 in the brain of children with AIDS. , 1998, The American journal of pathology.
[26] W. Karpus,et al. MIP‐1α and MCP‐1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphoctye differentiation , 1997, Journal of leukocyte biology.
[27] C. Mackay,et al. Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection. , 1997, The American journal of pathology.
[28] G. Stewart,et al. The CCR5 deletion mutation fails to protect against multiple sclerosis. , 1997, Human immunology.
[29] M. Baggiolini,et al. Chemotactic activity on mononuclear cells in the cerebrospinal fluid of patients with viral meningitis is mediated by interferon‐γ inducible protein‐10 and monocyte chemotactic protein‐1 , 1997, European journal of immunology.
[30] C. Mackay,et al. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. , 1997, Science.
[31] L. Steinman,et al. Perivascular T Cells Express the Pro‐Inflammatory Chemokine RANTES mRNA in Multiple Sclerosis Lesions , 1997, Scandinavian journal of immunology.
[32] Y. Inoue,et al. Identification of cell types producing RANTES, MIP-1α and MIP-1β in rat experimental autoimmune encephalomyelitis by in situ hybridization , 1997, Journal of Neuroimmunology.
[33] J. Frederiksen,et al. Serial Gadolinium‐enhanced MRI in untreated patients with acute optic neuritis: implications for natural history , 1997, Acta neurologica Scandinavica.
[34] W. Karpus,et al. Differential CC chemokine-induced enhancement of T helper cell cytokine production. , 1997, Journal of immunology.
[35] A. Sauter,et al. Differential and time-dependent expression of monocyte chemoattractant protein-1 mRNA by astrocytes and macrophages in rat brain: effects of ischemia and peripheral lipopolysaccharide administration , 1997, Journal of Neuroimmunology.
[36] J. Farber. Mig and IP‐10: CXC chemokines that target lymphocytes , 1997, Journal of leukocyte biology.
[37] K. Frei,et al. C-X-C and C-C chemokines are expressed in the cerebrospinal fluid in bacterial meningitis and mediate chemotactic activity on peripheral blood-derived polymorphonuclear and mononuclear cells in vitro. , 1997, Journal of immunology.
[38] R. Ransohoff,et al. Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. , 1997, The American journal of pathology.
[39] M. Rodriguez,et al. Indictment of the microglia as the villain in multiple sclerosis , 1997, Neurology.
[40] M. J. Verma,et al. Chemokines in acute anterior uveitis. , 1997, Current eye research.
[41] R. Strieter,et al. Transgenic methods to study chemokine function in lung and central nervous system. , 1997, Methods in enzymology.
[42] R. Ransohoff,et al. Expression of monocyte chemoattractant protein (MCP-1) and nitric oxide synthase-2 following cerebral trauma , 1997, Acta Neuropathologica.
[43] V G Sasseville,et al. Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis. , 1996, The American journal of pathology.
[44] K. Matsushima,et al. Preparation of specific polyclonal antibodies to a C-C chemokine receptor , CCR 1 , and determination of CCR 1 expression on various types of leukocytes , 2005 .
[45] V. Perry,et al. Recombinant Human Adenovirus with Rat MIP‐2 Gene Insertion Causes Prolonged PMN Recruitment to the Murine Brain , 1996, The European journal of neuroscience.
[46] Simon A. Jones,et al. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes , 1996, The Journal of experimental medicine.
[47] D. Gemsa,et al. Chemokines in the cerebrospinal fluid of patients with meningitis. , 1996, Clinical immunology and immunopathology.
[48] B. Trapp,et al. Neutrophil infiltration, glial reaction, and neurological disease in transgenic mice expressing the chemokine N51/KC in oligodendrocytes. , 1996, The Journal of clinical investigation.
[49] P. Vanguri,et al. Chronic intrathecal infusion of phosphorothioate or phosphodiester antisense oligonucleotides against cytokine responsive gene-2/IP-10 in experimental allergic encephalomyelitis of lewis rat. , 1996, The Journal of pharmacology and experimental therapeutics.
[50] Moses Rodriguez,et al. Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis , 1996, Brain pathology.
[51] R. Ransohoff,et al. Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain. , 1996, Journal of immunology.
[52] R. Ransohoff,et al. Chemokines in immune-mediated inflammation of the central nervous system. , 1996, Cytokine & growth factor reviews.
[53] L Steinman,et al. Multiple Sclerosis: A Coordinated Immunological Attack against Myelin in the Central Nervous System , 1996, Cell.
[54] C. Brosnan,et al. Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat. , 1996, Journal of immunology.
[55] L. Picker,et al. Lymphocyte Homing and Homeostasis , 1996, Science.
[56] M. Christiansen,et al. Qualitative assessment of intrathecal IgG synthesis by isoelectric focusing and immunodetection: interlaboratory reproducibility and interobserver agreement. , 1996, Scandinavian journal of clinical and laboratory investigation.
[57] R. Ransohoff,et al. In situ hybridization analysis of glial fibrillary acidic protein mRNA reveals evidence of biphasic astrocyte activation during acute experimental autoimmune encephalomyelitis. , 1996, The American journal of pathology.
[58] R. Bravo,et al. Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. , 1995, Journal of immunology.
[59] R. Ransohoff,et al. Central Nervous System Chemokine mRNA Accumulation Follows Initial Leukocyte Entry at the Onset of Acute Murine Experimental Autoimmune Encephalomyelitis , 1995, Brain, Behavior, and Immunity.
[60] R. Strieter,et al. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. , 1995, Journal of immunology.
[61] P. Gray,et al. Chemokine expression in murine experimental allergic encephalomyelitis , 1995, Journal of Neuroimmunology.
[62] T. Olsson. Critical Influences of the Cytokine Orchestration on the Outcome of Myelin Antigen‐Specific T‐Cell Autoimmunity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis , 1995, Immunological reviews.
[63] S. Kikuchi,et al. Macrophage inflammatory protein-1 alpha in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological diseases. , 1995, Journal of the neurological sciences.
[64] B. Engelhardt,et al. Lymphocytes infiltrating the CNS during inflammation display a distinctive phenotype and bind to VCAM-1 but not to MAdCAM-1. , 1995, International immunology.
[65] K. Schmid,et al. Possible role of tissue‐bound calcium ions in citrate‐mediated high‐temperature antigen retrieval , 1994, The Journal of pathology.
[66] R. Ransohoff,et al. Do Chemokines Mediate Inflammatory Cell Invasion of the Central Nervous System Parenchyma? , 1994, Brain pathology.
[67] P. Young,et al. Cytokine-induced neutrophil chemoattractant mRNA expressed in cerebral ischemia , 1993, Neuroscience Letters.
[68] J. Antel,et al. The attraction of adhesion molecules , 1993, Annals of neurology.
[69] A. Cross,et al. Anti-adhesion molecule therapy in experimental autoimmune encephalomyelitis , 1993, Journal of Neuroimmunology.
[70] R. Ransohoff,et al. Astrocyte expression of mRNA encoding cytokines IP‐10 and JE/MCP‐1 in experimental autoimmune encephalomyelitis , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[71] C. Brosnan,et al. Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis. , 1993, Journal of immunology.
[72] F. Sánchez‐Madrid,et al. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin , 1992, Nature.
[73] F. Sánchez‐Madrid,et al. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. , 1992, Nature.
[74] F. Da. Demyelinating optic neuritis: clinical features and differential diagnosis. , 1991 .
[75] D. Francis. Demyelinating optic neuritis: clinical features and differential diagnosis. , 1991, British journal of hospital medicine.
[76] Leonard,et al. Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. , 1990, The American journal of pathology.
[77] D. Compston. The management of multiple sclerosis. , 1989, The Quarterly journal of medicine.
[78] D. Silberberg,et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.
[79] W. Mcdonald. Diagnosis and management of optic neuritis. , 1976, Transactions of the Ophthalmological Society of New Zealand.